Today's Date
CD40L Antagonism in Rheumatoid Arthritis
(
CONTROL-RA
)
ITN Protocol #:
ITN092AI
Branded Name:
CONTROL-RA
ClinicalTrials.Gov ID:
NCT05306353Treatment Protocol #:
Therapeutic Area:
Autoimmune Disease
Current Status:
On Hold
Summary:
Combining a CD40L-Binding Protein (VIB4920) with a TNF-alpha Inhibitor for the Treatment of Inadequately Controlled Rheumatoid Arthritis
Clinical Operations Manager
ITN Biologist
Study Personnel:
